Skeletal overexpression of noggin results in osteopenia and reduced bone formation

Endocrinology

Volumn 144, Issue 5, 2003, Pages 1972-1978

  Devlin, R D ^a   Du, Z ^a,b   Pereira, R C ^a   Kimble, R B ^e   Economides, A N ^c   Jorgetti, V ^d   Canalis, Ernesto ^a,b  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c REGENERON PHARMACEUTICALS INC   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; NOGGIN; OSTEOCALCIN; CARRIER PROTEIN; NOGGIN PROTEIN; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE MINERAL; CALCULATION; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; FEMUR; FEMUR FRACTURE; GENE OVEREXPRESSION; HUMERUS FRACTURE; IN VIVO STUDY; LONG BONE; LUMBAR SPINE; MICRO-COMPUTED TOMOGRAPHY; MICROANALYSIS; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; TIBIA FRACTURE; TRABECULAR BONE; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; VERTEBRA; ANIMAL; BODY WEIGHT; BONE; BONE REMODELING; COMPUTER ASSISTED TOMOGRAPHY; GENETICS; METABOLIC BONE DISEASE; METABOLISM; PATHOLOGY; PHYSIOLOGY; RADIOGRAPHY; REFERENCE VALUE;

ANIMALS; BODY WEIGHT; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; BONE REMODELING; CARRIER PROTEINS; MICE; MICE, TRANSGENIC; OSTEOGENESIS; PROTEINS; REFERENCE VALUES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037733130     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220918     Document Type: Article

References (40)

1. Margolis RN, Canalis E, Partridge NC 1996 Anabolic hormones in bone: basic research and therapeutic potential. J Clin Endocrinol Metab 81:872-877
2. Pereira RC, Rydziel S, Canalis E 2000 Bone morphogenetic protein-4 regulates its own expression in cultured osteoblasts. J Cell Physiol 182:239-246
3. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM 1990 Identification of transforming growth factor B family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 87:9843-9847
4. Hughes FJ, Collyer J, Stanfield M, Goodman SA 1995 The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 136:2671-2677
5. Thies RS, Bauduy M, Ashton BA, Kurtzberg L, Wozney JM, Rosen V 1992 Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130:1318-1324
6. Schmitt JM, Hwang K, Winn SR, Hollinger JO 1999 Bone morphogenetic proteins: an update on basic biology and clinical relevance. J Orthop Res 17:269-278
7. Gazzero E, Gangji V, Canalis E 1998 Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J Clin Invest 102:2106-2114
8. Yamashita H, ten Dijke P, Heldin C-H, Miyazono K 1996 Bone morphogenetic protein receptors. Bone 19:569-574
9. Derynck R, Zhang Y, Feng X-H 1998 Smads: transcriptional activators of TGF-β responses. Cell 95:737-740
10. Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, Henis YI, Knaus P 2002 The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277:5330-5338
11. Onichtchouk D, Chen Y-G, Dosch R, Gawantka V, Delius H, Massague J, Niehrs C 1999 Silencing of TGFβ signaling by the pseudoreceptor BAMBI. Nature 401:480-485
12. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J-I, Kawabata M, Miyazono K 1997 Smad6 inhibits signaling by the TGF-β superfamily. Nature 389:622-626
13. Wang W, Mariani FV, Harland RM, Luo K 2000 Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells. Proc Natl Acad Sci USA 97:14394-14399
14. Yoshida Y, Tanaka S, Umemori H, Minowa O, Michihiko U, Ikematsu N, Hosoda E, Imamura T, Kuno J, Yamashita T, Miyazono K, Noda M, Noda T, Yamamoto T 2000 Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 103:1085-1097
15. Zhang Y, Chang C, Gehling DJ, Hemmati-Brivanlou A, Derynck R 2001 Regulation of Smad degradation and activity by Smurf2, and E3 ubiquitin ligase. Proc Natl Acad Sci USA 98:974-979
16. Valenzuela DM, Economides AN, Rojas E, Lamb TM, Nunez L, Jones P, Ip NY, Espinosa R, Brannan CI, Gilbert DJ, Copeland NG, Jenkins NA, LeBeau MM, Harland RM, Yancopoulos GD 1995 Identification of mammalian noggin and its expression in the adult nervous system. J Neurosci 15:6077-6084
17. Zimmerman LB, DeJesus-Escobar JM, Harland RM 1996 The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86:599-606
18. Smith WC, Harland RM 1992 Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell 70:829-840
19. Sasai Y, Lu B, Steinbeisser H, Geissert D, Gont LK, De Robertis EM 1994 Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes. Cell 79:779-790
20. Fainsod A, Deibler K, Yelin R, Marom K, Epstein M, Pillemer G, Steinbeisser H, Blum M 1997 The dorsalizing and neural inducing gene follistatin is an antagonist of BMP-4. Mech Dev 63:39-50
21. Pearce JJH, Penny G, Rossant J 1999 A mouse cerberus/Dan-related gene family. Dev Biol 209:98-110
22. Ross JJ, Shimmi O, Vilmos P, Petryk A, Kim H, Gaudenz K, Hermanson S, Ekker SC, O'Connor MB, Marsh JL 2001 Twisted gastrulation is a conserved extracellular BMP antagonist. Nature 410:479-482
23. Chang C, Holtzman DA, Chau S, Chickering T, Woolf EA, Holmgren LM, Bodorova J, Gearing DP, Holmes WE, Brivanlou AH 2001 Twisted gastrulation can function as a BMP antagonist. Nature 410:483-487
24. Aspenberg P, Jeppsson C, Economides AN 2001 The bone morphogenetic proteins antagonist noggin inhibits membranous ossification. J Bone Miner Res 16:497-500
25. Brunet LJ, McMahon JA, McMahon AP, Harland RM 1998 Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280:1455-1457
26. Gong Y, Krakow D, Marcelino J, Wilkin D, Chitayat D, Babul-Hirji R, Hudgins L, Cremers CW, Cremers FP, Brunner HG, Reinker K, Rimoin DL, Cohn DH, Goodman FR, Reardon W, Patton M, Francomano CA, Warman ML 1999 Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet 21:302-304
27. Abe E, Yamamoto M, Taguchi Y, Lecka-Czernik B, O'Brien CA, Economides AN, Stahl N, Jilka RL, Manolagas SC 2000 Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J Bone Miner Res 15:663-673
28. Frenkel B, Caparelli C, Van Auken M, Baran D, Bryan J, Stein JL, Stein GS, Lian JL 1997 Activity of the osteocalcin promoter in skeletal sites of transgenic mice and during osteoblast differentiation in bone marrow-derived stromal cell cultures: effects of age and sex. Endocrinology 138:2109-2116
29. Erlebacher A, Derynck R 1996 Increased expression of TGF-β2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 132:195-210
30. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC 1994 Green fluorescent protein as a marker for gene expression. Science 263:802-805
31. Devlin RD, Du Z, Buccilli V, Jorgetti V, Canalis E 2002 Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia. Endocrinology 143:3955-3962
32. Irwin N 1989 Molecular cloning. Sambrook J, Fritsch EF, Maniatis T, eds. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 9.32-9.36
33. Chomczynski P, Sacchi N 1987 Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
34. Nagy TR, Prince CW, Li J 2001 Validation of peripheral dual-energy x-ray absorptiometry for the measurement of bone mineral in intact and excised long bones of rats. J Bone Miner Res 16:1682-1687
35. Ruegsegger P, Koller B, Muller R 1996 A microtomographic system for the nondestructive evaluation of bone architecture. Calcif Tissue Int 58:24-29
36. Parfitt AM, Mathews CHE, Villaneuva AR, Kleerekoper M, Frame B, Rao DS 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner Res 2:595-610
37. Bouxsein ML, Turek TJ, Blake CA, D'Augusta D, Li X, Stevens M, Seeherman HJ, Wozney JM 2001 Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model. J Bone Joint Surg Am 83-A:1219-1230
38. Spinella-Jaegle S, Roman-Roman S, Faucheu C, Dunn F-W, Dawai S, Gallea S, Stiot V, Blanchet AM, Courtois B, Baron R, Rawadi G 2001 Opposite effects of bone morphogenetic protein-2 and transforming growth factor-β1 on osteoblast differentiation. Bone 29:323-330
39. Gazzerro E, Du Z, Devlin RD, Rydziel S, Priest L, Economides AN, Canalis E, Noggin arrests stromal cell differentiation in vitro. Bone, in press
40. Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue L-R, Malluche HH, Fagin JA, Clemens TL 2000 Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141:2674-2682